Sample Article - Use of Domperidone as a Prokinetic and Antiemetic

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Sample Articles from IJPC

About IJPC

The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly scientific and professional journal emphasizing quality pharmaceutical compounding.

The Journal is available in both printed and electronic format with digital versions of individual articles and complete issues delivered in Adobe® Acrobat PDF format.

Search the Journal by issue, topic or keyword.

Request a free copy of the Journal

Request a copy of
"Use of Domperidone as a Prokinetic and Antiemetic"

Read Abstract

A link to this sample article download page may be freely posted on web sites, chat rooms, and message boards provided that attribution to IJPC is included. The URL for this item is http://ijpc.com/Sample/Article.cfm?SID=85

The sample document may NOT be electronically posted, published, or redistributed without the prior permission of IJPC.

Complete the following to have a download link emailed to you.

Name:
Email:
Organization:
Used For:

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles
Use of Domperidone as a Prokinetic and Antiemetic Albright Lisa M	Mar/Apr 2005 Pg. 120-125 View Sample
Domperidone 5 mg/mL in Oral Mix Allen Loyd V Jr	Jul/Aug 2019 Pg. 316
Compounding Prokinetic Medications for Companion Animals Gaskins Jessica	Jul/Aug 2012 Pg. 276-286
Domperidone 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 500
Nausea and Vomiting in Hospice Patients Boomsma Diane	Jul/Aug 2000 Pg. 250-251
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Phan Ha, DeReese Annie, Day A J, Carvalho Maria	May/Jun 2014 Pg. 203-207
Domperidone 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 61
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Moon Richard B	Mar/Apr 2006 Pg. 95-98
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Zur Eyal	Mar/Apr 2013 Pg. 113-123
Antiemetic Suppositories of the Gralla Type Allen Loyd V Jr	Jan/Feb 1997 Pg. 28
Antiemetic Injection for Cancer Chemotherapy Allen Loyd V Jr	May/Jun 1997 Pg. 175
Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection Allen Loyd V Jr	Sep/Oct 1997 Pg. 328
Metoclopramide 5-mg/mL Injection Allen Loyd V Jr	May/Jun 2012 Pg. 243
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O	Sep/Oct 2016 Pg. 426-434
Domperidone in Lactation: Use as a Galactagogue Albright Lisa M	Sep/Oct 2004 Pg. 329-335
Domperidone Capsules 10-, 20- and 30-mg Albright Lisa M	Sep/Oct 2004 Pg. 332
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Muller George	May/Jun 2009 Pg. 220-221
Transdermals: The Skin as Part of a Drug Delivery System Allen Loyd V Jr	Jul/Aug 2011 Pg. 308-315
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 419
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Gupta Vishnu D	Jul/Aug 2008 Pg. 372-374
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A	Jul/Aug 2008 Pg. 368-371
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A	Sep/Oct 2008 Pg. 460-462
Granisetron 0.05-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 222
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A, Zhang Yanping	May/Jun 2006 Pg. 234-236
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A	Nov/Dec 2007 Pg. 520-524
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A	May/Jun 2005 Pg. 235-237
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A	May/Jun 2005 Pg. 238-241
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D	May/Jun 2005 Pg. 242-246
Dolasetron 10-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 475
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate Wu George, Yeung Stanley, Chen Frank	Jan/Feb 2017 Pg. 66-75
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Wu George, Yeung Stanley, Chen Frank	Jan/Feb 2017 Pg. 76-82
Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel Allen Loyd V Jr	Nov/Dec 2017 Pg. 495
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Wu George, Powers Dan, Yeung Stanley, Chen Frank	Jan/Feb 2018 Pg. 76-85
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly	Jan/Feb 2018 Pg. 86-94
Prochlorperazine Edisylate 0.5% Nasal Spray Allen Loyd V Jr	Mar/Apr 2018 Pg. 150
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Allen Loyd V Jr	May/Jun 2018 Pg. 237
Dexamethasone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 225
Prochlorperazine 5-mg/mL Injection Allen Loyd V Jr	May/Jun 2012 Pg. 246
Promethazine Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 163
Ondansetron Hydrochloride 2-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2012 Pg. 339
Granisetron 1-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 66
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott	May/Jun 2013 Pg. 247-253
Droperidol 2.5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 62
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy	Nov/Dec 2014 Pg. 520-525
Scopolamine Hydrobromide -.4-mg/mL Injection Allen Loyd V Jr	May/Jun 2015 Pg. 247
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Anderson Collin R, Halford Zachery, MacKay Mark	Jul/Aug 2015 Pg. 344-347
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Allen Loyd V Jr	Nov/Dec 2015 Pg. 507
Aprepitant 80-mg Capsules Allen Loyd V Jr	Jan/Feb 2016 Pg. 48
Dolasetron Mesylate 20-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2016 Pg. 318
Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Allen Loyd V Jr	Sep/Oct 2020 Pg. 406
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Nov/Dec 2022 Pg. 513
Migraine Headache Suppositories Allen Loyd V Jr	May/Jun 2023 Pg. 237
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature Gupta Vishnu D	Jan/Feb 2005 Pg. 72-74
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Gupta Vishnu D	Nov/Dec 2005 Pg. 484-486
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn	Mar/Apr 2006 Pg. 147-153
Hospice from a Compounding Pharmacist's Perspective Jones Marty	Mar/Apr 2006 Pg. 89-93
BAD (Benadryl, Ativan, and Decadron) Intravenous Drip Allen Loyd V Jr	Nov/Dec 2004 Pg. 469
Custom-Making Medications for the Hospice Patient Horwitz Robert	Jul/Aug 2000 Pg. 255-256
The Symptom Relief Kit for Hospice Patients Petrin Ronald L	Mar/Apr 1998 Pg. 116-117
Dimenhydrinate 5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2003 Pg. 217
Chlorpromazine HCl 30-mg/mL Oral Concentrate Allen Loyd V Jr	Jul/Aug 2003 Pg. 297
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A	Mar/Apr 2008 Pg. 156-160
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A	Mar/Apr 2008 Pg. 170-173
Promethazine Hydrochloride 2.5-mg/mL Rectal Solution Allen Loyd V Jr	May/Jun 2008 Pg. 267
Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model Bassani August S, Banov Daniel, Lehman Paul A	May/Jun 2008 Pg. 270-273
Hospice Symptom Relief Kit: An Update Petrin Ronald L	Jul/Aug 2006 Pg. 288-290
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel	Jan/Feb 2009 Pg. 78-80
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Allen Loyd V Jr	Nov/Dec 2011 Pg. 504
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes McCluskey Susan V, Lovely Jenna K	Mar/Apr 2011 Pg. 170-173
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice McNulty John P, Muller George	May/Jun 2014 Pg. 190-200
Hydroxyzine Hydrochloride 25-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 418
Diphenhydramine Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2012 Pg. 334
Lorazepam 4-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 161
A Concise Discussion of Headache Types, Part 2: Migraine Williams LaVonn A	May/Jun 2012 Pg. 182-188
Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle Allen Loyd V Jr	Jul/Aug 2020 Pg. 319
Ondansetron Hydrochloride 0.8mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2007 Pg. 158
Lorazepam 1 mg/mL in Anhydrous Organic Solvent System Allen Loyd V Jr	Jul/Aug 2019 Pg. 317
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard	Mar/Apr 2020 Pg. 168-175
Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Allen Loyd V Jr	Mar/Apr 2018 Pg. 151
Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients McElhiney Linda F	Jan/Feb 2018 Pg. 30-39
BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Allen Loyd V Jr	Jul/Aug 2021 Pg. 322
Lorazepam 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 143
Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle Allen Loyd V Jr	May/Jun 2022 Pg. 236
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A	Jan/Feb 2007 Pg. 82-85
Return to Top